Based in Belgium, this venture capital firm focuses on investing in startups primarily in the biotechnology and medical device industries. They have a strong track record of exits and typically invest in rounds with 1-2 participants. Some of their notable portfolio companies include RetinAI Medical AG, Hylomorph, and Smart Reporting. The firm is active in 2-6 deals per year, with investments ranging from $1-5 million. They have a preference for startups with fewer founders and those that are 4-5 years old. Despite being founded in Europe, their most frequent investments are in Switzerland.